VKVR
General Information
DCTPep ID DCTPep01123
Peptide Name VKVR
Sequence VKDGYIVDDKNCAYFCGRNAYCDDECEKNGAESGYCQWAGVYGNACWCYKLPDKVPIRVPGRCNG
Sequence Length 65
UniProt ID G4V3T9
PubChem CID Not available
Origin Scorpion
Type Native peptide
Classification
ACP Tumor active peptide
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
Mouse S180 sarcoma | Mouse S180 sarcoma | At a dose of 4.4 mg/kg body weight, the tumor weight inhibition rate was 46% | Antitumor in vivo | 7 days | Patent |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure DCTPep01123
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C313H463N87O97S8
Absent amino acids HMT
Theoretical pI 5.13
Acidic residues 9
Basic residues 8
Polar residues 28
Molecular weight (Average) 7253.12
Molecular weight (Monoisotopic) 7248.17
Common amino acids CG
Net charge -1
Instability index (II) 17.05
Aliphatic index 48.00
Grand average of hydropathicity (GRAVY) -0.589
Half Life
100 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 20440
Abs 0.1% (=1 g/l) 2.818, assuming all pairs of Cys residues form cystines
Ext. coefficient 19940
Abs 0.1% (=1 g/l) 2.749, assuming all Cys residues are reduced
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID CN102690342B
Patent Title Anti-cancer analgesic peptide VKVR, its preparation method and application
Other Iinformation Granted Patent; Family: 2s/2ex; Family Jurisdictions: CN; Legal Status: Active; Application No: 201110069002; Filed: Mar 22, 2011; Published: Oct 29, 2014; Earliest Priority: Mar 22, 2011; Granted: Oct 29, 2014
Other Published ID CN102690342B